ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Jonathan J BeitlerHarry QuonChristopher U JonesJoseph K SalamaPaul M BusseJay S CooperShlomo A KoyfmanJohn A RidgeNabil F SabaFarzan SiddiquiRichard V SmithFrancis WordenMin YaoSue S Yomnull nullPublished in: Head & neck (2016)
T1 to T2N0M0 resectable oropharyngeal SCC can be treated with surgery or radiation without chemotherapy. Patients with T1-2N1-2aM0 disease can receive radiation, chemoradiation, or transoral surgery with neck dissection and appropriate adjuvant therapy. Patients with T1-2N2b-3M0 disease should receive chemoradiation or transoral surgery with neck dissection and appropriate adjuvant therapy. Concurrent chemoradiation is preferred for T3 to T4 disease. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1299-1309, 2016.